| 摘要 |
Provided by the present invention is a method for treating von Willebrand Disease (vWD) by administering a cytokine, such as IL-11, IL-6, LIF, OSM, or CNTF. The present invention relates generally to novel methods for treating bleeding disorders and more specifically relates to methods for treating von Willebrand Disease (vWD) hemophilia A, and various hemostatic disorders such as uremia, cirrhosis, congenital platelet defects, congenital and acquired storage pool deficiency, patients with unexplained prolongations of bleeding time, as well as prophylactic treatment before surgeries. |
